SCHEMBL22011400

SCHEMBL22011400

c1ccc2c(-c3cccc4c3oc3ccccc34)nc(-n3c4ccccc4c4c5ccc6oc7ccccc7c6c5c5c6ccccc6oc5c43)nc2c1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.32
PIK3CD O00329 1/20 0.32
PIK3CB P42338 1/20 0.32
ALOX5 P09917 2/20 0.32
ADK P55263 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986110 0.91 PRKDC (0.34) PRKDCPIK3CDPIK3CBALOX5ADK
SCHEMBL22199964 0.91 PRKDC (0.35) PRKDCPIK3CDPIK3CBALOX5ADK
SCHEMBL22011405 0.91 LMNA (0.31)
SCHEMBL14756492 0.89 PRKDC (0.34) PRKDCPIK3CDPIK3CBALOX5ADK
SCHEMBL22011396 0.88 HPGD (0.41)
SCHEMBL24171376 0.87 L3MBTL1 (0.34)
SCHEMBL17405352 0.86 PIK3CD (0.32) PRKDCPIK3CDPIK3CBALOX5
SCHEMBL22011404 0.86 L3MBTL1 (0.34)
SCHEMBL22011401 0.86 HPGD (0.40)
SCHEMBL19986112 0.86 NPC1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 PRKDC 3551/4885PIK3CD 4851/4885PIK3CB 4876/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 PRKDC 3551/4885PIK3CD 4851/4885PIK3CB 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.